型IIポリケチド合成酵素を,型II非リボソームペプチド合成酵素メカニズムを通じてプライミングする
Miho Izumikawa1, Qian Cheng, Bradley S Moore
1College of Pharmacy, University of Arizona, Tucson, Arizona 85721, USA.
Journal of the American Chemical Society
|February 2, 2006
まとめ
研究者らは,ベンゾ酸を用いたポリケチド合成酵素をプライミングするための新しいメカニズムを発見した. このATPに依存するプロセスには,特定の酵素とアシルキャリアタンパク質が関与し,多様な芳香性ポリケチド剤の生成を可能にします.
科学分野:
- バイオケミストリー バイオケミストリー
- 分子生物学は分子生物学である.
- 合成生物学 合成生物学とは
背景:
- II型ポリケチド合成酵素は,多様な芳香化合物の生成に不可欠である.
- プライミングメカニズムを理解することは,新しいポリケチド構造を設計する鍵です.
研究 の 目的:
- タイプIIポリケチド合成酵素複合体のベンゾ酸プライミングのインビトロメカニズムを解明する.
- アリル酸がアシルキャリアタンパク質に転移する酵素とコファクターを研究する.
主な方法:
- 放射性標識された基板を用いたインビトロ生化学測定法.
- プロテイン質量スペクトロメトリーは,中間物質と改変を特定する.
- ネイティブおよび人工合成のケトシンタゼ/鎖長因子ヘテロダイマーへの基板移転の実証.
主要な成果:
- ベンゾ酸プライミングは,新しい非リボソーム性ペプチド合成酵素のようなメカニズムを通じて発生します.
- ベンゾ酸:アシルキャリアタンパク質 (ACP) リガゼ EncNとACP EncCは,このプライミングに不可欠です.
- アリル酸のACPへの移転はATPに依存し,共酵素Aに依存しない.
- ACPに結合したアリル基は,標的のポリケチド合成酵素複合体へと成功裏に転送される.
結論:
- この研究は,アリル原型ポリケチド合成のための前例のない生物触媒経路を明らかにしています.
- 特定されたメカニズムは,多様なアリル原料の芳香性ポリケチド剤を設計するための強力なツールを提供します.
- この研究は,薬剤発見と天然製品の合成に重大な影響を及ぼします.
さらに関連する動画
08:09Isolation of Rat Adipose Tissue Mesenchymal Stem Cells for Differentiation into Insulin-producing Cells
Published on: August 29, 2022
03:39Preparation of Frozen Non-Human Primate Fetal Islets for Combined Single Nuclei RNA-Sequencing and ATAC-Sequencing, and Bulk Metabolomics
Published on: November 8, 2024
関連する概念動画
01:25Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
01:26Biosynthesis of Polysaccharides
Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.